{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:37:10Z","timestamp":1763545030325,"version":"3.45.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03966-2","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:24:55Z","timestamp":1763544295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A systems biology approach to identify key targets in KRAS\/BRAF-mutated colorectal cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Shiva","family":"Shiravi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Mottaghi-Dastjerdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Soltany-Rezaee-Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abozar","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Montazeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"3966_CR1","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. (2024) Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer 2024. https:\/\/gco.iarc.fr\/today\/en"},{"key":"3966_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag C, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72:338\u201344.","journal-title":"Gut"},{"key":"3966_CR3","doi-asserted-by":"publisher","first-page":"9073","DOI":"10.3390\/ijms24109073","volume":"24","author":"PM Potocki","year":"2023","unstructured":"Potocki PM, W\u00f3jcik P, Chmura \u0141, Goc B, Fedewicz M, Biela\u0144ska Z, Swad\u017aba J, Konopka K, Kwinta \u0141, Wysocki PJ. Clinical characterization of targetable mutations (BRAF V600E and KRAS G12C) in advanced colorectal Cancer\u2014A Nation-Wide study. Int J Mol Sci. 2023;24:9073.","journal-title":"Int J Mol Sci"},{"key":"3966_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.radonc.2009.10.001","volume":"94","author":"J Gaedcke","year":"2010","unstructured":"Gaedcke J, Grade M, Jung K, Schirmer M, Jo P, Obermeyer C, Wolff HA, Herrmann MK, Beissbarth T, Becker H. KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy. Radiother Oncol. 2010;94:76\u201381.","journal-title":"Radiother Oncol"},{"key":"3966_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.21037\/jgo.2019.01.10","volume":"10","author":"L Midthun","year":"2019","unstructured":"Midthun L, Shaheen S, Deisch J, Senthil M, Tsai J, Hsueh C-T. Concomitant KRAS and BRAF mutations in colorectal cancer. J Gastrointest Oncol. 2019;10:577.","journal-title":"J Gastrointest Oncol"},{"key":"3966_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0065-2423(10)51004-7","volume":"51","author":"B Markman","year":"2010","unstructured":"Markman B, Javier Ramos F, Capdevila J, Tabernero J. EGFR and KRAS in colorectal cancer. Adv Clin Chem. 2010;51:71\u2013119. https:\/\/doi.org\/10.1016\/s0065-2423(10)51004-7.","journal-title":"Adv Clin Chem"},{"key":"3966_CR7","doi-asserted-by":"crossref","unstructured":"Zeissig MN, Ashwood LM, Kondrashova O, Sutherland KD. Next batter up! Targeting cancers with KRAS-G12D mutations. Trends in Cancer. 2023.","DOI":"10.1016\/j.trecan.2023.07.010"},{"key":"3966_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1200\/EDBK_349561","volume":"42","author":"J Tabernero","year":"2022","unstructured":"Tabernero J, Ros J, \u00c9lez E. The evolving treatment landscape in BRAF-V600E\u2013mutated metastatic colorectal cancer. Am Soc Clin Oncol Educational Book. 2022;42:254\u201363.","journal-title":"Am Soc Clin Oncol Educational Book"},{"key":"3966_CR9","unstructured":"Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M, Sepehrizadeh Z, Roshandel G, Ebrahimifard F, Setayesh N. Gene expression profiling revealed overexpression of vesicle amine transport protein-1 (VAT-1) as a potential oncogene in gastric cancer. 2016."},{"key":"3966_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0960327114532386","volume":"34","author":"N Mottaghi-Dastjerdi","year":"2015","unstructured":"Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M, Sepehrizadeh Z, Roshandel G, Ebrahimifard F, Setayesh N. Identification of novel genes involved in gastric carcinogenesis by suppression subtractive hybridization. Hum Exp Toxicol. 2015;34:3\u201311.","journal-title":"Hum Exp Toxicol"},{"key":"3966_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2008-2231-22-14","volume":"22","author":"N Mottaghi-Dastjerdi","year":"2014","unstructured":"Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M, Sepehrizadeh Z, Roshandel G, Ebrahimifard F, Setayesh N. Genome expression analysis by suppression subtractive hybridization identified overexpression of Humanin, a target gene in gastric cancer chemoresistance. DARU J Pharm Sci. 2014;22:1\u20137.","journal-title":"DARU J Pharm Sci"},{"key":"3966_CR12","doi-asserted-by":"publisher","first-page":"185035","DOI":"10.1155\/2014\/185035","volume":"2014","author":"M Soltany-Rezaee-Rad","year":"2014","unstructured":"Soltany-Rezaee-Rad M, Mottaghi-Dastjerdi N, Setayesh N, Roshandel G, Ebrahimifard F, Sepehrizadeh Z. Overexpression of FOXO3, MYD88, and GAPDH identified by suppression subtractive hybridization in esophageal cancer is associated with autophagy. Gastroenterol Res Pract. 2014;2014:185035.","journal-title":"Gastroenterol Res Pract"},{"key":"3966_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12672-024-01225-4","volume":"15","author":"F Khoshdel","year":"2024","unstructured":"Khoshdel F, Mottaghi-Dastjerdi N, Yazdani F, Salehi S, Ghorbani A, Montazeri H, Soltany-Rezaee-Rad M, Goodarzy B. CTGF, FN1, IL-6, THBS1, and WISP1 genes and PI3K-Akt signaling pathway as prognostic and therapeutic targets in gastric cancer identified by gene network modeling. Discover Oncol. 2024;15:344.","journal-title":"Discover Oncol"},{"key":"3966_CR14","unstructured":"Amerizadeh F, Rahmani F, Ghorbani A, Mottaghi-Dastjerdi N, Bazyari MJ, Rouhani J, Pasdar AA. Prospective to regulatory role of Mirnas on Wnt\/\u0392-Catenin signaling and its crosstalk to the other cellular pathways in tumorigenesis of glioblastoma by a systems biology approach. \u0392-Catenin signaling and its crosstalk to the other cellular pathways in tumorigenesis of glioblastoma by a systems biology approach."},{"key":"3966_CR15","unstructured":"Yazdani F, Mottaghi-Dastjerdi N, Ghorbani A, Soltany-Rezaee-Rad M, Montazeri H, Khoshdel F, Guzzi PH. Identification of key genes and pathways governing T-DM1 resistance in OE-19 esophageal cancer cells through bioinformatics analysis. 2013."},{"key":"3966_CR16","doi-asserted-by":"publisher","first-page":"11572","DOI":"10.3389\/av.2024.11572","volume":"68","author":"N Farsiu","year":"2024","unstructured":"Farsiu N, Ghorbani A, Karbanowicz TP, Mottaghi-Dastjerdi N, Veltri P, Guzzi PH. Discovery of long non-coding RNAs in na\u00efve CD4\u2009+\u2009T cells in response to initiating antiretroviral therapy at acute or chronic phase of HIV-1 infection. Acta Virol. 2024;68:11572.","journal-title":"Acta Virol"},{"key":"3966_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12876-023-02891-4","volume":"23","author":"N Mottaghi-Dastjerdi","year":"2023","unstructured":"Mottaghi-Dastjerdi N, Ghorbani A, Montazeri H, Guzzi PH. A systems biology approach to pathogenesis of gastric cancer: gene network modeling and pathway analysis. BMC Gastroenterol. 2023;23:248.","journal-title":"BMC Gastroenterol"},{"key":"3966_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016;1418:93\u2013110. https:\/\/doi.org\/10.1007\/978-1-4939-3578-9_5.","journal-title":"Methods Mol Biol"},{"key":"3966_CR19","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80. https:\/\/doi.org\/10.1186\/gb-2004-5-10-r80.","journal-title":"Genome Biol"},{"key":"3966_CR20","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS. GEOquery: a Bridge between the gene expression omnibus (GEO) and bioconductor. Bioinformatics. 2007;23:1846\u20137.","journal-title":"Bioinformatics"},{"key":"3966_CR21","doi-asserted-by":"crossref","unstructured":"Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology 2004;3.","DOI":"10.2202\/1544-6115.1027"},{"key":"3966_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57:289\u2013300.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"3966_CR23","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u201346.","journal-title":"Nucleic Acids Res"},{"key":"3966_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2010","unstructured":"Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2010;27:431\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btq675.","journal-title":"Bioinformatics"},{"key":"3966_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma\u2019ayan A. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128. https:\/\/doi.org\/10.1186\/1471-2105-14-128.","journal-title":"BMC Bioinformatics"},{"key":"3966_CR26","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u201397. https:\/\/doi.org\/10.1093\/nar\/gkw377.","journal-title":"Nucleic Acids Res"},{"key":"3966_CR27","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, Lachmann A, Wojciechowicz ML, Kropiwnicki E, Jagodnik KM, et al. Gene set knowledge discovery with enrichr. Curr Protocols. 2021;1:e90. https:\/\/doi.org\/10.1002\/cpz1.90.","journal-title":"Curr Protocols"},{"key":"3966_CR28","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3390\/ijms18091880","volume":"18","author":"M Li","year":"2017","unstructured":"Li M, Li D, Tang Y, Wu F, Wang J. CytoCluster: a cytoscape plugin for cluster analysis and visualization of biological networks. Int J Mol Sci. 2017;18:1880.","journal-title":"Int J Mol Sci"},{"key":"3966_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res. 2000;28:235\u201342.","journal-title":"Nucleic Acids Res"},{"key":"3966_CR30","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u201312.","journal-title":"J Comput Chem"},{"key":"3966_CR31","first-page":"11","volume":"29","author":"L J\u00e4ntschi","year":"2011","unstructured":"J\u00e4ntschi L. Computer assisted geometry optimization for in Silico modeling. Appl Med Inf. 2011;29:11\u20138.","journal-title":"Appl Med Inf"},{"key":"3966_CR32","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. J Comput Chem. 2009;30:2785\u201391.","journal-title":"J Comput Chem"},{"key":"3966_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361.","journal-title":"J Comput Chem"},{"key":"3966_CR34","doi-asserted-by":"crossref","unstructured":"Yuan S, Chan HS, Hu Z. Using PyMOL as a platform for computational drug design. Wiley Interdisciplinary Reviews: Computational Molecular Science 2017;7: e1298.","DOI":"10.1002\/wcms.1298"},{"key":"3966_CR35","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41467-023-39953-w","volume":"14","author":"E Koncina","year":"2023","unstructured":"Koncina E, Nurmik M, Pozdeev VI, Gilson C, Tsenkova M, Begaj R, Stang S, Gaigneaux A, Weindorfer C, Rodriguez F, et al. IL1R1\u2009+\u2009cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer. Nat Commun. 2023;14:4251. https:\/\/doi.org\/10.1038\/s41467-023-39953-w.","journal-title":"Nat Commun"},{"key":"3966_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1476-4598-11-87","volume":"11","author":"Y Li","year":"2012","unstructured":"Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J. IL-1\u03b2 promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Mol Cancer. 2012;11:87. https:\/\/doi.org\/10.1186\/1476-4598-11-87.","journal-title":"Mol Cancer"},{"key":"3966_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41523-021-00305-w","volume":"7","author":"C Tulotta","year":"2021","unstructured":"Tulotta C, Lefley DV, Moore CK, Amariutei AE, Spicer-Hadlington AR, Quayle LA, Hughes RO, Ahmed K, Cookson V, Evans CA, et al. IL-1B drives opposing responses in primary tumours and bone metastases; Harnessing combination therapies to improve outcome in breast cancer. Npj Breast Cancer. 2021;7:95. https:\/\/doi.org\/10.1038\/s41523-021-00305-w.","journal-title":"Npj Breast Cancer"},{"key":"3966_CR38","doi-asserted-by":"publisher","first-page":"888392","DOI":"10.3389\/fimmu.2022.888392","volume":"13","author":"DD Arnold","year":"2022","unstructured":"Arnold DD, Yalamanoglu A, Boyman O. Systematic review of safety and efficacy of IL-1-Targeted biologics in treating Immune-Mediated disorders. Front Immunol. 2022;13:888392. https:\/\/doi.org\/10.3389\/fimmu.2022.888392.","journal-title":"Front Immunol"},{"key":"3966_CR39","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.1158\/0008-5472.Can-19-3176","volume":"80","author":"CC Wong","year":"2020","unstructured":"Wong CC, Baum J, Silvestro A, Beste MT, Bharani-Dharan B, Xu S, Wang YA, Wang X, Prescott MF, Krajkovich L, et al. Inhibition of IL1\u03b2 by Canakinumab May be effective against diverse molecular subtypes of lung cancer: an exploratory analysis of the CANTOS trial. Cancer Res. 2020;80:5597\u2013605. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-3176.","journal-title":"Cancer Res"},{"key":"3966_CR40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jaad.2020.10.085","volume":"84","author":"R Bissonnette","year":"2021","unstructured":"Bissonnette R, Gold LS, Rubenstein DS, Tallman AM, Armstrong A. Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic Aryl hydrocarbon receptor\u2013modulating agent. J Am Acad Dermatol. 2021;84:1059\u201367.","journal-title":"J Am Acad Dermatol"},{"key":"3966_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-498","volume":"14","author":"U-H Jin","year":"2014","unstructured":"Jin U-H, Lee S-O, Pfent C, Safe S. The Aryl hydrocarbon receptor ligand Omeprazole inhibits breast cancer cell invasion and metastasis. BMC Cancer. 2014;14:1\u201314.","journal-title":"BMC Cancer"},{"key":"3966_CR42","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1021\/tx5005198","volume":"28","author":"U-H Jin","year":"2015","unstructured":"Jin U-H, Kim S-B, Safe S. Omeprazole inhibits pancreatic cancer cell invasion through a nongenomic Aryl hydrocarbon receptor pathway. Chem Res Toxicol. 2015;28:907\u201318.","journal-title":"Chem Res Toxicol"},{"key":"3966_CR43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12964-024-01667-x","volume":"22","author":"R Rosell","year":"2024","unstructured":"Rosell R, Jantus-Lewintre E, Cao P, Cai X, Xing B, Ito M, Gomez-Vazquez JL, Marco-Jord\u00e1n M, Calabuig-Fari\u00f1as S, Cardona AF. KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on Tepotinib and Omeprazole combination. Cell Communication Signal. 2024;22:324.","journal-title":"Cell Communication Signal"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03966-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03966-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03966-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:25:09Z","timestamp":1763544309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03966-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3966"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03966-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This bioinformatics study was reviewed and approved by the Ethical Committee of Iran University of Medical Sciences (ethical code: IR.IUMS.REC.1402.999). As the study is based on publicly available datasets, patient consent was not required. The Ethical Committee of Iran University of Medical Sciences confirmed that patient consent was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"This study does not involve human research participants; therefore, consent to publish is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2130"}}